Buprenorphine FAQ and Peer Discussion
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Frequently asked questions about buprenorphine care; chapter in the Integration of Buprenorphine into HIV Primary Care document.
Resource updated 05/22/2024
U.S. HIV-related treatment guidelines, drug database, and glossary.
Resource updated 09/20/2023
Resource updated 04/23/2024
The Health Insurance Portability and Accountability Act (HIPAA) requires health care providers to assure patient confidentiality and other patient rights. This resource assists Ryan White grantees, their contractors, and subgrantees in complying with these requirements.
Resource updated 09/19/2023
Healthcare providers can receive no-cost expert clinical consultation in HIV prevention & care, HCV treatment, and substance use management.
Resource updated 09/20/2023
HIV clinical training resources for HRSA's AIDS Education and Training Centers Program.
Resource updated 04/17/2024
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
Tool for service and program monitoring.
Resource updated 09/19/2023
Service delivery, billing, and documentation guidelines by Dallas County Part A.
Resource updated 09/19/2023
Federal guidelines for treatment, prevention and care of HIV disease, opportunistic infections, and common co-infections.
Resource updated 09/19/2023
Advice for RWHAP grant recipients who have multiply-funded subrecipients.
Resource updated 09/14/2023
Resource updated 05/15/2024
Resource updated 03/08/2024